Aligning mRNA Progress With Regulatory Streamlining - Episode 7

The Future of Manufacturing, Safety, and Collaboration

Published on: 
, , , ,

Sponsored

The panel highlights the need for continued research, collaboration between stakeholders, and a strategic approach to leveraging mRNA's capabilities to address unmet clinical needs.

EP. 1: The Benefits of Working with mRNA for Therapeutics
EP. 2: Public Perception and Communicating the Potential and Safety of mRNA
EP. 3: Lessons from Vaccine Development and Future Possibilities
EP. 4: Streamlining Rare Disease Drug Development
EP. 5: Navigating Challenges and Embracing Opportunities to Optimize mRNA Therapies
EP. 6: Overcoming Delivery Challenges of mRNA Therapeutics
Now Viewing
EP. 7: The Future of Manufacturing, Safety, and Collaboration

The panel discussed the current state of mRNA medicine, highlighting gaps in research and development, and the need for continued innovation to improve safety and efficacy. The panelists also spoke on the importance of real-world clinical data and collaboration among stakeholders.

Discussion Topics

  • 00:07 - Current state and future potential of the mRNA field
  • 00:28 - Continued research needed to address gaps in mRNA technology, such as delivery mechanisms, immunogenicity, and long-term safety
  • 01:18 - Importance of real-world clinical data and building trust through collaboration between stakeholders
  • 03:37 - Need for a consortium of patient advocates, pharma, biotech, academia, and regulators to accelerate progress in mRNA medicine
  • 03:45 - Excitement about the potential of mRNA technology and the need to use it wisely to push boundaries